Celsion Falls Most Ever After Liver Cancer Drug Fails

Celsion Corp. plunged the most ever in New York trading after the company announced its experimental treatment for liver cancer failed in a study.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.